Skip to main content

Table 1 Clinical characteristics

From: Cortical vein thrombosis in adult patients of cerebral venous sinus thrombosis correlates with poor outcome and brain lesions: a retrospective study

 

Total

CVT group

Non-CVT group

P Value

(n = 44)

(n = 27)

(n = 17)

Age (mean ± SD), y

33.8 ± 14.0

32.6 ± 13.5

35.7 ± 14.9

0.484

Male, n (%)

28(63.6)

19(70.4)

9(52.9)

0.242

Duration from onset of symptoms to hospital arrival (median, range)

9,1~30

7,1~30

14,4~30

0.116

Clinical symptoms, n (%)

 Headache

39(88.6)

22(81.5)

17(100)

0.139

 Seizure

19(43.2)

17(63.0)

2(11.8)

0.001

 Focal neurological deficit

13(29.5)

12(44.4)

1(5.9)

0.006

 Consciousness disorders

9(20.5)

9(33.3)

0(0)

0.008

Etiology, n (%)

0.493

 Infection

5(11.4)

4(14.8)

1(5.9)

 

 Pregnancy/puerperium

5(11.4)

3(11.1)

2(11.8)

 

 Coagulation dysfunction

16(36.4)

11(40.7)

5(29.4)

 

 Autoimmune diseases

5(11.4)

3(11.1)

2(11.8)

 

 Malignancy

4(9.1)

3(11.1)

1(5.9)

 

 Undetermined source

9(20.5)

3(11.1)

6(35.3)

 

Treatment, n (%)

 Anticoagulation

34(77.3)

21(77.8)

13(76.5)

1.000

 Decompression Surgery

1(3.7)

1(3.7)

0(0)

1.000

mRS at discharge (median, range)

1,0~6

2,1~4

0,0~4

 

 0~2, n (%)

31(70.5)

16(59.3)

15(88.2)

0.040

 3~6, n (%)

13(29.5)

11(40.7)

2(11.8)

 
  1. CVT indicates cortical vein thrombosis; mRS modified Rankin Scale, SD standard deviation